Schedule 13D ownership disclosure

Liminal BioSciences Inc.

Security class unavailable · CUSIP: 53272L103

Event date: 2020-10-29

Legacy cover-page extraction is best effort and may not include every reporting person.

Filing-level shares
Unavailable
Percent of class
70.9000%

Amounts are as disclosed in this filing. Schedule type alone does not establish investment intent.

Source: SEC EDGAR filing

Filing metadata

Accession number
0001104659-20-122651
Form type
SC 13D
Filer
Liminal BioSciences Inc.
CIK
CIK 1351172
Filed
Nov 09, 2020
Reporting period
Oct 29, 2020
Description
Schedule 13D beneficial ownership

Explore SEC Filings Hub